Immunotherapy against several tumors, such as lung cancer, including NSCLC Grant US-11161880-B2 United States of America 02 Nov 2021
NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER INCLUDING NSCLC Application EP-3616710-A1 European Patent Office 04 Mar 2020